Cambridge, UK OncoSpan features the largest gene coverage of any oncology reference standard Allows the most comprehensive validation of oncology gene panels and large-scale exome sequencing assays OncoSpan is supplied with free-of-charge access to online NGS validation and quality control (QC) tool, OncoMatic Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon” or “the Company”), a global leader […]
ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that its leading, integrated “one space” genomics workflow and analysis solution, Clinical Genomicist Workspace (CGW), now supports clinical microarray (CMA) technology. CMA is commonly used in the constitutional setting to evaluate complex developmental disorders and is used to identify potential copy number […]
Concord, MA – N-of-One, Inc., the leader in clinical interpretation of molecular tests in oncology, is proud to announce the incorporation of the recent AMP guidelines on reporting somatic cancer variants with enhanced levels of evidence (LOE) into N-of-One’s existing curation and reporting. In December of 2016, to address the field’s need for consistent interpretation and […]
SAN DIEGO – Edico Genome today announced the availability of its DRAGENTM Bio-IT Platform on Illumina’s BaseSpace® Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data. Powered by Amazon Web Services’ (AWS) new reconfigurable Field Programmable Gate Array (FPGA) enabled F1 instances, Edico Genome’s ultra-rapid DRAGEN Genome Pipeline features optimized […]
36 leading biopharmaceutical companies now participate in this unique global modeling and simulation research group PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that Kyowa Hakko Kirin Co., Ltd. has joined the Simcyp Consortium and licensed the Simcyp® Population-based Simulator. Kyowa Hakko Kirin is the 36th leading biopharmaceutical company […]
OAKLAND, Calif. & SAN FRANCISCO, Calif.–Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing examination of its patients’ genomic data to augment data […]
LAUSANNE, Switzerland SOPHiA GENETICS, the global leader in Data-Driven Medicine that has created SOPHiA Artificial Intelligence, today announced the close of a $30 million Series D funding round. The round was led by London-based Balderton Capital joined by 360º Capital Partners alongside existing investors British tech star Mike Lynch’s Invoke Capital and Alychlo, the investment firm of Belgian pharmaceutical entrepreneur Marc Coucke. […]
Qlucore, a leader in the development of bioinformatics visualization software, has today launched the latest version of its advanced data analysis software. Qlucore Omics Explorer 3.3 includes a new Next Generation Sequencing (NGS) Module and additional new functionalities. Qlucore Omics Explorer is a next-generation bioinformatics software program for broad usage, known for its easy to […]
SAN DIEGO – Edico Genome today announced the commercial deployment of its DRAGENTM Bio-IT Platform on Amazon Web Services (AWS) Marketplace, enabled by the recent general availability of the Amazon Elastic Compute Cloud (Amazon EC2) F1 instance type. Amazon EC2 F1 instances are powered by Xilinx Virtex UltraScale+ field programmable gate arrays (FPGAs) and are designed to provide capabilities for […]
BC|RQUEST provides researchers direct access to genomic and phenotypic data from the United States and Europe BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data. BC|RQUEST facilitates browsing and analytics of genomic and clinical data that […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
